465 related articles for article (PubMed ID: 20375904)
1. RGS2 expression and aldosterone: renin ratio modulate response to drug therapy in hypertensive patients.
Semplicini A; Strapazzon G; Papparella I; Sartori M; Realdi A; Macchini L; Calò LA; Ceolotto G
J Hypertens; 2010 May; 28(5):1104-8. PubMed ID: 20375904
[TBL] [Abstract][Full Text] [Related]
2. Does aldosterone-to-renin ratio predict the antihypertensive effect of the aldosterone antagonist spironolactone?
Mahmud A; Mahgoub M; Hall M; Feely J
Am J Hypertens; 2005 Dec; 18(12 Pt 1):1631-5. PubMed ID: 16364838
[TBL] [Abstract][Full Text] [Related]
3. Reduced expression of regulator of G-protein signaling 2 (RGS2) in hypertensive patients increases calcium mobilization and ERK1/2 phosphorylation induced by angiotensin II.
Semplicini A; Lenzini L; Sartori M; Papparella I; Calò LA; Pagnin E; Strapazzon G; Benna C; Costa R; Avogaro A; Ceolotto G; Pessina AC
J Hypertens; 2006 Jun; 24(6):1115-24. PubMed ID: 16685212
[TBL] [Abstract][Full Text] [Related]
4. Aldosterone and refractory hypertension: a prospective cohort study.
Sartori M; Calò LA; Mascagna V; Realdi A; Macchini L; Ciccariello L; De Toni R; Cattelan F; Pessina AC; Semplicini A
Am J Hypertens; 2006 Apr; 19(4):373-9; discussion 380. PubMed ID: 16580572
[TBL] [Abstract][Full Text] [Related]
5. Aldosterone excess and resistance to 24-h blood pressure control.
Pimenta E; Gaddam KK; Pratt-Ubunama MN; Nishizaka MK; Cofield SS; Oparil S; Calhoun DA
J Hypertens; 2007 Oct; 25(10):2131-7. PubMed ID: 17885558
[TBL] [Abstract][Full Text] [Related]
6. Aldosterone to renin ratio as a determinant of exercise blood pressure response in hypertensive patients.
Lim PO; Donnan PT; MacDonald TM
J Hum Hypertens; 2001 Feb; 15(2):119-23. PubMed ID: 11317191
[TBL] [Abstract][Full Text] [Related]
7. The influence of serum aldosterone and the aldosterone-renin ratio on pulse wave velocity in hypertensive patients.
Park S; Kim JB; Shim CY; Ko YG; Choi D; Jang Y; Chung N
J Hypertens; 2007 Jun; 25(6):1279-83. PubMed ID: 17563542
[TBL] [Abstract][Full Text] [Related]
8. Normokalemic hyperaldosteronism in patients with resistant hypertension.
Benchetrit S; Bernheim J; Podjarny E
Isr Med Assoc J; 2002 Jan; 4(1):17-20. PubMed ID: 11802302
[TBL] [Abstract][Full Text] [Related]
9. CYP2C9 genotype modifies activity of the renin-angiotensin-aldosterone system in hypertensive men.
Donner KM; Hiltunen TP; Suonsyrjä T; Hannila-Handelberg T; Tikkanen I; Antikainen M; Hirvonen A; Kontula K
J Hypertens; 2009 Oct; 27(10):2001-9. PubMed ID: 19593208
[TBL] [Abstract][Full Text] [Related]
10. [Profile on circadian blood pressure and the influencing factors in essential hypertensive patients after treatment].
Qiu YG; Yao XY; Tao QM; Zheng P; Chen JZ; Zhu JH; Zhang FR; Zheng LR; Zhao LL
Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Aug; 25(8):710-4. PubMed ID: 15555399
[TBL] [Abstract][Full Text] [Related]
11. [The captopril test--an aid in the detection of scarring nephropathy as a cause of arterial hypertension in children].
Peco-Antić A; Nastić-Mirić D; Babić D; Kostić M
Srp Arh Celok Lek; 1999; 127(9-10):305-11. PubMed ID: 10649899
[TBL] [Abstract][Full Text] [Related]
12. The cutoff value of aldosterone-to-renin ratio for the diagnosis of primary aldosteronism in patients taking antihypertensive medicine.
Niizuma S; Nakahama H; Kamide K; Fukuchi K; Iwanaga Y; Nakata H; Yoshihara F; Horio T; Nakamura S; Kawano Y
Clin Exp Hypertens; 2008 Oct; 30(7):640-7. PubMed ID: 18855267
[TBL] [Abstract][Full Text] [Related]
13. The prevalence of a raised aldosterone-renin ratio (ARR) among new referrals to a hypertension clinic.
Williams D; Croal B; Furnace J; Ross S; Witte K; Webster M; Critchen W; Webster J
Blood Press; 2006; 15(3):164-8. PubMed ID: 16864158
[TBL] [Abstract][Full Text] [Related]
14. The future of antihypertensive treatment.
Israili ZH; Hernández-Hernández R; Valasco M
Am J Ther; 2007; 14(2):121-34. PubMed ID: 17414579
[TBL] [Abstract][Full Text] [Related]
15. Aldosterone-to-renin ratio, arterial stiffness, and the response to aldosterone antagonism in essential hypertension.
Mahmud A; Feely J
Am J Hypertens; 2005 Jan; 18(1):50-5. PubMed ID: 15691617
[TBL] [Abstract][Full Text] [Related]
16. Aldosterone/renin ratio determines peripheral and central blood pressure values over a broad range.
Tomaschitz A; Maerz W; Pilz S; Ritz E; Scharnagl H; Renner W; Boehm BO; Fahrleitner-Pammer A; Weihrauch G; Dobnig H
J Am Coll Cardiol; 2010 May; 55(19):2171-80. PubMed ID: 20447545
[TBL] [Abstract][Full Text] [Related]
17. RGS2 C1114G polymorphism and body weight gain in hypertensive patients.
Sartori M; Ceolotto G; Dorigatti F; Mos L; Santonastaso M; Bratti P; Papparella I; Semplicini A; Palatini P;
Metabolism; 2008 Mar; 57(3):421-7. PubMed ID: 18249218
[TBL] [Abstract][Full Text] [Related]
18. Renin and age as determinants of a predominantly betablocker-based antihypertensive drug program.
Bühler FR; Lütold BE
Adv Nephrol Necker Hosp; 1976; 6():303-17. PubMed ID: 14485
[TBL] [Abstract][Full Text] [Related]
19. Blood pressure and neurohormonal responses to renal nerve ablation in treatment-resistant hypertension.
Ezzahti M; Moelker A; Friesema EC; van der Linde NA; Krestin GP; van den Meiracker AH
J Hypertens; 2014 Jan; 32(1):135-41. PubMed ID: 24131897
[TBL] [Abstract][Full Text] [Related]
20. Blood pressure and serum potassium levels in hypertensive patients receiving or not receiving antihypertensive treatment.
Pikilidou MI; Lasaridis AN; Sarafidis PA; Tziolas IM; Zebekakis PE; Dombros NV; Giannoulis E
Clin Exp Hypertens; 2007 Nov; 29(8):563-73. PubMed ID: 18058481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
